IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 212 filers reported holding IMMUNOMEDICS INC in Q3 2019. The put-call ratio across all filers is 0.35 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $19,027,000 | +169.0% | 1,434,900 | +181.4% | 0.46% | +141.9% |
| Q2 2019 | $7,072,000 | -27.8% | 509,900 | 0.0% | 0.19% | -27.4% |
| Q1 2019 | $9,795,000 | +34.6% | 509,900 | 0.0% | 0.26% | +25.2% |
| Q4 2018 | $7,276,000 | -31.5% | 509,900 | 0.0% | 0.21% | -27.1% |
| Q3 2018 | $10,621,000 | -12.0% | 509,900 | 0.0% | 0.29% | -15.8% |
| Q2 2018 | $12,069,000 | – | 509,900 | – | 0.34% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,711,067 | $2,943,000 | 1.70% |
| J.P. Turner & Co Capital Mnagement, LLC | 248,625 | $428,000 | 0.44% |
| Orbimed Advisors | 3,323,000 | $5,716,000 | 0.06% |
| BALYASNY ASSET MANAGEMENT L.P. | 2,004,078 | $3,447,000 | 0.02% |
| WOLVERINE ASSET MANAGEMENT LLC | 5,870 | $1,018,000 | 0.02% |
| SIGNET FINANCIAL MANAGEMENT, LLC | 44,675 | $77,000 | 0.02% |
| SVB WEALTH LLC | 195,000 | $335,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 288,900 | $497,000 | 0.01% |
| J.P. Turner & Co Capital Mnagement, LLC | 153,900 | $8,000 | 0.01% |
| BALYASNY ASSET MANAGEMENT L.P. | 640,400 | $1,101,000 | 0.01% |